A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms

NARecruitingINTERVENTIONAL
Enrollment

215

Participants

Timeline

Start Date

February 10, 2025

Primary Completion Date

December 31, 2032

Study Completion Date

December 31, 2032

Conditions
Benign Prostatic Hyperplasia
Interventions
DEVICE

FloStent

Flexible cystoscopy to deploy medical device used to treat BPH

DEVICE

Sham (Control)

Flexible Cystoscopy without deployment of medical device used to treat BPH

Trial Locations (20)

2500

NOT_YET_RECRUITING

South Coast Urology, Wollongong

10016

RECRUITING

Manhattan Medical Research NYU Langone, New York

11791

NOT_YET_RECRUITING

Northwell Health, Syosset

27612

RECRUITING

Associated Urologists of North Carolina, Raleigh

32114

RECRUITING

Advanced Urology Institute, Daytona Beach

38138

RECRUITING

Conrad Pearson Clinic, Germantown

48084

RECRUITING

Michigan Institute of Urology, Troy

60153

NOT_YET_RECRUITING

Loyola Medicine, Maywood

60532

RECRUITING

Duly Health, Lisle

70508

RECRUITING

Southern Urology, Lafayette

77030

NOT_YET_RECRUITING

Houston Methodist, Houston

78705

RECRUITING

Midtown Urology Associates, Austin

78759

RECRUITING

Urology Austin/Urology America, Austin

80122

RECRUITING

Urology Denver, Littleton

89144

RECRUITING

Sheldon Freedman Urology, Las Vegas

90017

RECRUITING

Urology Group of Southern California, Los Angeles

90048

RECRUITING

Comprehensive Urology Medical Group, Beverly Hills

91942

RECRUITING

Atlas Men's Health, La Mesa

92780

RECRUITING

Prestige Medical Group, Tustin

93301

RECRUITING

Michael G Oefelein Clinical Trials, Bakersfield

All Listed Sponsors
lead

Rivermark Medical

INDUSTRY